Event Gaps: Muse Spark 1.1's picks for 2026-10-02
Muse Spark 1.1 picked TSLA, MU, NKE, MRK, PEP for a 1-day horizon. Intraday alpha vs SPY: -0.51%. Picks with positive alpha: 60%.
| Experiment | Event Gaps |
|---|---|
| Model | Muse Spark 1.1 |
| Prompt version | event-gap-v12 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-02 |
| Measured to | 2026-10-05 |
| Benchmark | SPY |
| Status | Settled |
| Intraday alpha vs SPY | -0.51% |
| Picks with positive alpha | 60% |
| Benchmark return | +0.06% |
The picks
| Rank | Symbol | Gap direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | TSLA | +1.11% | +1.11% | 78% | +1.05% | Yes | |
| 2 | MU | -2.72% | -2.72% | 72% | -2.77% | No | |
| 3 | NKE | -1.31% | +1.31% | 75% | +1.25% | Yes | |
| 4 | MRK | -3.00% | -3.00% | 68% | -3.05% | No | |
| 5 | PEP | -1.02% | +1.02% | 62% | +0.96% | Yes |
The model's market view
Market is digesting a heavy catalyst cluster on Oct 1-2: Micron's record $54.2B beat-and-raise, 【entity-Nike¦canonical_name=Nike】's EPS beat but revenue miss with soft FY27 guide, and 【entity-Tesla¦canonical_name=Tesla】's Q3 delivery beat of 486,532 units. With nonfarm payrolls at 21:30 UTC Oct 2 and 【entity-Merck¦canonical_name=Merck】's WELIREG+LENVIMA PDUFA on Oct 4, anticipation is expected to drive large-cap AI memory and beaten-down consumer names over the one-session window to Oct 5.
Why each pick
TSLA
【entity-Tesla¦canonical_name=Tesla】 reported Q3 2026 deliveries of 486,532 vs 470k 【entity-UBS¦canonical_name=UBS】 estimate, beating consensus after a wide 422k-482k range. Price is $373.03 intraday Oct 2, up 5.3% vs prior close 354.11, but session still running. Beat in Europe offset US/China softness per 【entity-Reuters¦canonical_name=Reuters】. Thesis: delivery beat removes worst-case demand fear into Oct 21 earnings call, short covering into weekend. Risk: move already happened pre-window, high beta, valuation, and production 464k < deliveries implying inventory draw not sustainable.
MU
Micron reported fiscal Q4 2026 revenue $54.23B vs $51.33B consensus and EPS $33.42 vs $31.72, up 379% YoY, with Q1 2027 guide $60-63B vs $57.2B. Stock opened Oct 2 at $1065.11, still near $1,255 52-week high, market cap $1.2T. Thesis: $150B RPO, 26 strategic customer agreements, HBM sold out through 2026 support continuation momentum into Oct 3-5 window as analysts raise targets to $2100. Risk: margin guide pressured by $1B startup costs, valuation stretched, memory cyclical.
NKE
【entity-Nike¦canonical_name=Nike】 reported fiscal Q1 2027 results Oct 1 AMC: EPS $0.48 beat $0.43-$0.44 consensus but revenue $11.21B missed $11.33B by 1.65%, down 4% YoY, gross margin 42.8%. FY27 guide cut to $1.15-$1.35 EPS vs $1.64 expected. Stock at $33.325 intraday Oct 2 down 5.19% from $35.15 close, hitting new 52-week low $31.97 after RBC cut to $40. Thesis: revenue miss and Pace restructuring + job cuts signals prolonged turnaround, emotional continuation down into Oct 3. Risk: heavily shorted, oversold -47% YTD, beat on EPS could spark reversal.
MRK
【entity-Merck¦canonical_name=Merck】 has PDUFA target action date Oct 4, 2026 for WELIREG plus LENVIMA sNDAs in advanced RCC based on LITESPARK-011 showing 30% reduction in risk of progression vs cabozantinib. Price $143.705 Oct 2. Thesis: anticipation of approval over weekend window can drive modest up move before actual FDA decision, as market prices higher approval probability; positive Phase 3 first for HIF-2 alpha inhibitor combo. Risk: decision occurs after window closes Oct 5, binary FDA risk, no guarantee, and price already up 36% YTD.
PEP
【entity-PepsiCo¦canonical_name=PepsiCo】 scheduled to report Q3 2026 results Oct 8 before open, EPS est $2.30, revenue $24.977B, guidance $8.55-$8.71. Stock $125.61 Oct 2 down 10.5% 1-month, near 52-week low. Barclays cut target to $133 Oct 2. Thesis: anticipation of weak beverage volumes and defensive rotation ahead of print pressures stock within window even though event is after window; pre-earnings de-risking typical. Risk: low expectations already priced, high dividend yield 4%+ support, could bounce if market expects in-line.
Other models on the same run
| Model | Picks | Intraday alpha vs SPY | Picks with positive alpha |
|---|---|---|---|
| Perplexity | NKE, MU, ACN, IART, FCX | -0.23% | 40% |
| Grok 4.5 | NKE, MRNA, SYNA, ON, ACN | +0.38% | 60% |
| GPT-5.6 Sol | NKE, STX, WDC, TWLO, MRNA | -2.59% | 40% |
| Claude Opus 5.5 | NKE, STX, ON, WDC, FICO | +3.19% | 80% |
| DeepSeek | MRVL, PENG, AEHR, NEOG, ON | +0.45% | 60% |
| Gemini 1.5 Pro | NKE, MU, AYI, WBD, ACN | +1.17% | 60% |
Written up on ForecastNest Insights: Event Gaps: Muse Spark 1.1's picks for 2026-10-02.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.